Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,294
Total Claims
$1.4M
Drug Cost
1,938
Beneficiaries
$710
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+24%
Opioid rate vs peers
2.8% vs 2.2% avg
-50%
Cost per patient vs peers
$710 vs $1,411 avg
-26%
Brand preference vs peers
7.9% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.8%
Opioid Rate
508
Opioid Claims
$4,707
Opioid Cost
4.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,430 claims · $1.1M
Generic: 16,755 claims · $290K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 189 | $247K |
| Semaglutide | 64 | $105K |
| Rivaroxaban | 64 | $97K |
| Empagliflozin | 53 | $74K |
| Fluticasone/Umeclidin/Vilanter | 35 | $46K |
| Mirabegron | 39 | $37K |
| Dulaglutide | 16 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 24 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $18K |
| Insulin Aspart | 17 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $17K |
| Atorvastatin Calcium | 1,317 | $14K |
| Levothyroxine Sodium | 995 | $14K |
| Fluticasone Propion/Salmeterol | 13 | $14K |
| Dapagliflozin Propanediol | 12 | $13K |
Prescribing Profile
Patient Profile
78
Avg Age
50%
Female
1.21
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About